Key points are not available for this paper at this time.
Mangrove-derived microorganism is a promising and important resource of novel natural products and lead compounds for drug discovery. This study aimed to find microbial secondary metabolites with novel structures. Based on the bioactive-guided screening of mangrove-derived actinomycetes, Streptomyces sp. GP3T5 was studied owing to its antibacterial, antibiofilm and anti-fungi activities. Three compounds (1-3) were isolated from the fermentation broth by organic solvent extraction, reversed-phase chromatography, Sephadex LH20 gel chromatography, and preparative high-performance liquid chromatography. Their structures were identified as pyrisulfoxin A (compound 1), collismycin A (compound 2), and echinomycin A (compound 3), respectively, via high resolution electrospray ionization mass spectroscopy (HRESIMS), nuclear magnetic resonance (NMR), ultraviolet (UV) spectroscopy. The activity evaluation of compounds 1-3 revealed that all three compounds showed antibacterial and antibiofilm activities. Compound 3 showed potent antibacterial activity against foodborne pathogens with minimum inhibitory concentrations (ρMIC) of 0.06 μg/mL for Listeria monocytogenes and Streptococcus agalactiae. The minimum biofilm inhibitory concentrations (ρMBIC) of compounds 1-3 against Acinetobacter baumannii were 32 μg/mL, 16 μg/mL, and 1 μg/mL, respectively. Compounds 2 and 3 showed good antifungal activity against plant pathogenic fungi, with half maximal inhibitory concentrations (IC50) ≤ 10 μg/mL and ≤ 1 μg/mL, respectively. In conclusion, these results on strain GP3T5 derived from mangroves provide valuable insights for further exploration of bioactive compounds from mangrove soil microorganisms.
Zhang et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: